Copyright
©The Author(s) 2015.
World J Crit Care Med. Aug 4, 2015; 4(3): 202-212
Published online Aug 4, 2015. doi: 10.5492/wjccm.v4.i3.202
Published online Aug 4, 2015. doi: 10.5492/wjccm.v4.i3.202
Points (0, 1, or 2 for each of 4 categories: maximum possible score = 8) | |||
2 | 1 | 0 | |
Thrombocytopenia | > 50% fall or platelet nadir ≥ 20 × 109/L | 30%-50% fall or platelet count 10-19 × 109/L | Fall < 30% or platelet nadir < 10 × 109/L |
Timing of fall in platelet count | Clear onset between day 5-101; or less than 1 d (if history of heparin exposure within 30 d) | Consistent with d 5-10 fall, but not clear (e.g., missing platelet counts) or onset of thrombocytopenia after d10 or fall ≤ 1 d (prior heparin exposure 30-100 d ago) | Platelet count fall < 4 d without recent heparin exposure |
Thrombosis or other sequelae (e.g., Skin lesions) | New thrombosis; skin necrosis; acute systemic reaction post unfractionated heparin bolus | Progressive or recurrent thrombosis; erythematous skin lesions; suspected thrombosis not yet proven | None |
Other cause of thrombocytopenia | None apparent | Possible other cause is evident | Definite |
4T score: 6-8 = High; 4-5 = Intermediate; 0-3 = Low |
- Citation: Gupta S, Tiruvoipati R, Green C, Botha J, Tran H. Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrums. World J Crit Care Med 2015; 4(3): 202-212
- URL: https://www.wjgnet.com/2220-3141/full/v4/i3/202.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v4.i3.202